<DOC>
	<DOCNO>NCT02361528</DOCNO>
	<brief_summary>The concept acquire immunodeficiency first severe infection ICU widely describe literature . There dual risk : increased mortality increase secondary infection . Several approach immunostimulatory treatment propose literature . The treatment propose study consist administration Granulocyte-macrophage colony-stimulating factor ( GM-CSF ) , colony stimulate factor widely use particularly USA market . A phase 2 clinical trial conduct Germany 2009 . The main objective measure incidence ICU-acquired infection 2 group patient treat GM-CSF placebo . ICU patient risk define survive D3 severe sepsis septic shock present sepsis associate immunodepression . The detection immunosuppressed patient achieve measure HLA-DR ( Human Leucocyte Antigen DR ) threshold less 8000 site . Our hypothesis number secondary infection ( primary endpoint ) significantly reduce treat group .</brief_summary>
	<brief_title>GM-CSF Decrease ICU Acquired Infections</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<criteria>ICU patient present severe sepsis septic shock associate sepsisinduced immunosuppression . 1 . Severe sepsis OR septic shock define association : least 2 criterion Systemic Inflammation Response Syndrome ( SIRS ) clinically microbiologically defined infection respectively least one organ failure ( level ≥ 2 one organ failure SOFA score ) OR need vasopressor treatment ( epinephrine norepinephrine ≥ 0,25mg/kg/min least 6 hr maintain systolic pressure ≥ 90 mmHg mean arterial pressure ≥ 65 mmHg ) . 2 . AND Sepsisinduced immunosuppression : reduce mHLADR level ( &lt; 8,000 monoclonal antibody ( mAb ) per cell D3 ) . 1 . Therapeutic limitation 2 . Evolutive hemopathy , neutropenia &lt; 500/mm3 , stemcell transplant 3 . Solid tumor ongoing chemotherapy radiotherapy 4 . Human immunodeficiency virus ( HIV ) infection CD 4 count &lt; 200 cell/mm3 5 . Immunosuppressive treatment ( include corticosteroid immunosuppressive dose : &gt; 10 mg equivalent prednisolone cumulative dose &gt; 700 mg ) 6 . Primary immunodeficiency . 7 . Extra corporeal circulation within one month 8 . Recent cardiopulmonary resuscitation ( within current clinical episode ) 9 . Patients admit ICU extensive burn 10 . Contraindications sargramostim 11 . Pregnant lactate woman 12 . Participation another interventional study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Septic shock</keyword>
	<keyword>Severe sepsis</keyword>
	<keyword>GM-CSF</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Hospital-acquired infection</keyword>
	<keyword>ICU-acquired infection</keyword>
	<keyword>HLA-DR</keyword>
	<keyword>Monocytes</keyword>
</DOC>